Specialty pharmaceuticals firm Eurolife Healthcare has entered into an agreement to acquire Baxter Indias form-fill-seal (FFS) infusion business for an undisclosed amount.
The acquisition will allow Eurolife to consolidate its position as a prominent player in the segment and expand its FFS infusion manufacturing capacity, Eurolife Healthcare said in a statement. The company, however, did not provide any financial details of the proposed acquisition. “Eurolife is totally committed to making significant investments in the acquired facilities, in order to expand capacity to feed our flourishing FFS infusions business both locally and globally,” Eurolife Healthcare CEO Sandeep Toshniwal said. Following the close of the transaction, Eurolife Healthcare will have a pan-India FFS infusions manufacturing presence in Maharashtra, Tamil Nadu and Uttarakhand, the company said.